Metastatic Ovarian Carcinoma

Explore clinical trials studying Metastatic Ovarian Carcinoma. Study availability and eligibility vary by location and protocol.

16 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

Metastatic Ovarian Carcinoma trial results

Active, Not Recruiting

NCT04550494

Conditions: Adnexal Diseases, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, +64 more
Locations: UF Health Cancer Institute - Gainesville Gainesville, Florida, United States

National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States

National Institutes of Health Clinical Center Bethesda, Maryland, United States

University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States

Active, Not Recruiting

NCT02650986

Conditions: Adnexal Diseases, Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Neoplasm, +78 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

Active, Not Recruiting

NCT02627443

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +26 more
Locations: Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States

Mayo Clinic in Arizona Scottsdale, Arizona, United States

UCHealth University of Colorado Hospital Aurora, Colorado, United States

UF Health Cancer Institute - Gainesville Gainesville, Florida, United States

View all 14 locations

Active, Not Recruiting

NCT05075993

Active, Not Recruiting

NCT04514484

Conditions: Adenocarcinoma, Adnexal Diseases, Advanced Differentiated Thyroid Gland Carcinoma, +141 more
Locations: Northwestern University Chicago, Illinois, United States

Montefiore Medical Center-Einstein Campus The Bronx, New York, United States

University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States

Active, Not Recruiting

NCT04673448

Conditions: Adnexal Diseases, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, +53 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States